Корекція цитокінового профілю при аутоімунних захворюваннях кріоконсервованими продуктами ембріофетоплацентрного комплексу

In this work, we experimentally substantiated the possibility of correcting the cytokine profile to reduce the inflammation in mice with adjuvant arthritis (AA) via combined use of lyophilized human cord blood leukoconcentrate (lHCBL) and cryopreserved human placental extract (cHPE). Adjuvant arthri...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2022
Автори: Goltsev, Anatoliy, Lutsenko, Olena, Yampolska, Kateryna, Gaevska , Yuliia, Bondarovych , Mykola, Ostankova, Lyudmyla, Sokil , Larisa, Stepaniuk , Lyudmyla, Grisha , Ihor
Формат: Стаття
Мова:Англійська
Опубліковано: Publishing House ‘Akademperiodyka’ of the National Academy of Sciences of Ukraine; Institute for Problems of Cryobiology and Cryomedicine 2022
Теми:
Онлайн доступ:https://cryo.org.ua/journal/index.php/probl-cryobiol-cryomed/article/view/1793
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Problems of Cryobiology and Cryomedicine

Репозитарії

Problems of Cryobiology and Cryomedicine
Опис
Резюме:In this work, we experimentally substantiated the possibility of correcting the cytokine profile to reduce the inflammation in mice with adjuvant arthritis (AA) via combined use of lyophilized human cord blood leukoconcentrate (lHCBL) and cryopreserved human placental extract (cHPE). Adjuvant arthritis was modelled in CBA/H mice. To day 7 after pathology induction, the animals were injected with lHCBL and cHPE singly or in combination. To days 14 and 28 of observation, all the introduced products showed a therapeutic effect. To 28 day of observation, the efficiency of combined use of lHCBL and cHPE was 3.1 and 2.5 times higher vs. the monotherapy (respectively), likely resulting from their synergy in respect to a decrease in arthritis index, TNFα concentration, impact of lHCBL and cHPE on IFNγ and IL-6 levels, correspondingly.  Probl Cryobiol Cryomed 2022; 32(2):121–133